Lv416
750 积分 2024-10-07 加入
Drug-related visual blurring: findings from the U.S. Food and Drug Administration Adverse Event Reporting System database
1个月前
已完结
Comment on: Drugs That Interact With Colchicine via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)
2个月前
已完结
Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS)
2个月前
已完结
Diligent use of MedDRA terminology and preferred term selection in safety reports of clinical trials
2个月前
已关闭
Ocular toxicity associated with anti‐HER2 agents in breast cancer: A pharmacovigilance analysis using the FAERS database
2个月前
已完结
Postmarketing Safety of Sacituzumab Govitecan: A Pharmacovigilance Study Based on the FDA Adverse Event Reporting System
2个月前
已完结
Trabectedin in Cancers: Mechanisms and Clinical Applications
2个月前
已完结
Metformin adverse event profile: a pharmacovigilance study based on the FDA Adverse Event Reporting System (FAERS) from 2004 to 2022
3个月前
已完结
Cardioprotective effect of crocin in patients with breast cancer receiving anthracycline-based chemotherapy: A randomized, double-blind, placebo-controlled study
4个月前
已完结
Navigating cardiotoxicity risk in cancer therapy: the importance of the HFA-ICOS score
6个月前
已完结
皖公网安备34019202002308
